Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Mezigdomide overcomes CRBN mutations emerging post IMiD therapy

Edmond Watson, Chad Bjorklund, Nicholas Stong, Scott Hollingsworth, Olivia Pierce, Yilin Meng, Veerabahu Shanmugasundaram, Ting-Hsiang Huang, Vinidhra Sridharan, Tracy Chow, Michael Amatangelo, Patrick Hagner, Anita Gandhi

Blood (2025) 146 (Supplement 1): 436.

https://doi.org/10.1182/blood-2025-436

Published: 2025

Journal Articles

Phase 1 study of ktx-1001, a first-in-class oral MMSET/NSD2 inhibitor, demonstrates clinical activity in relapsed/refractory multiple myeloma

Blood (2025) 146 (Supplement 1): 250.

https://doi.org/10.1182/blood-2025-250

Published: 2025

Journal Articles

Ktx-1001, a potent, selective MMSET/NSD2 inhibitor, enhances immunomodulatory and immune-directed therapies in preclinical models of multiple myeloma

Vinidhra Sridharan, Devi Nandana, Hui Xian Choo, Vicki Gamble, Anjan Thakurta, Erin Flynt

Blood (2025) 146 (Supplement 1): 7456.

https://doi.org/10.1182/blood-2025-7456

Published: 2025

Journal Articles

BCMA Mutational Screening Reveals Differential Cytotoxic Activity between T-Cell Engagers in Preclinical Co-Culture Models

Vinidhra Sridharan, Hsiling Chiu, Shirong Li, Chad C. Bjorklund, Anita K. Gandhi, Patrick R. Hagner

Blood (2024) 144 (Supplement 1): 4650.

https://doi.org/10.1182/blood-2024-211024

Published: 2024

Journal Articles

Iberdomide Enhances Dara Mediated Cytotoxicity through Upregulation of CDC Activity and Elevated NK Cell Mediated ADCC

Peilin Ma, Vinidhra Sridharan, Krista Wollerman, Debjani Dutta, Ram Kumar Singh, Sambuddo Mukherjee, Chad C. Bjorklund, Patrick R Hagner, Michael Amatangelo, Anita K. Gandhi

Blood (2023) 142 (Supplement 1): 3289.

https://doi.org/10.1182/blood-2023-189423

Published: 2023